Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001733 · ClinicalTrials.gov registry record
Screening for Studies on Retinovascular Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00001733 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 2,000 participants.
The verdict
NCT00001733 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
This screening protocol is designed to help recruit patients for National Eye Institute (NEI) studies of the retina, such as diabetic retinopathy and macular degeneration. Patients must meet the specific criteria of a research study, and this protocol serves as a first step for admitting patients to a retinal disease study. Candidates will undergo a medical history and comprehensive eye examination. The eye examination includes dilation of the pupils to fully examine the retina. In some studies, photographs of the eye are required. This is done using fluorescein angiography. In this procedure, a dye called sodium fluorescein is injected into the blood stream through a vein. After the dye reaches the blood vessels of the eye, photographs are taken of the retina. Other diagnostic procedures may include physical examination, questionnaires, routine laboratory tests and other standard or specialized tests, as needed. When the screening is completed, patients will be informed of their options to participate in a study. Patients who are ineligible for a current study will be informed of alternative treatments or options. No treatment is offered under this protocol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 1998-03-06 |
| Est. Completion | 2008-07-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001733
The ClinicalTrials.gov registry entry for NCT00001733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001733 about?
NCT00001733 is a clinical study titled "Screening for Studies on Retinovascular Diseases". This screening protocol is designed to help recruit patients for National Eye Institute (NEI) studies of the retina, such as diabetic retinopathy and macular degeneration. Patients must meet the specific criteria of a research study, and this protocol serves as a first step for admitting patients to...
What is the current status of trial NCT00001733?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 1998-03-06. Estimated completion is 2008-07-02.
Who is sponsoring clinical trial NCT00001733?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.